Synapse Open Synapse
Biology

STAT+: Lilly says ‘triple-G’ drug beat Novo’s Ozempic in diabetes study

STAT News · · 1 min read

Data add to expectations that the drug will be one of Lilly’s greatest growth drivers.

Latest from STAT News